APA

Kornblau S. M., Gandhi V., Andreeff H. M., Beran M., Kantarjian H. M., Koller C. A., O'Brien S., Plunkett W. & Estey E. (19961024). Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults. : Leukemia.

Chicago

Kornblau S M, Gandhi V, Andreeff H M, Beran M, Kantarjian H M, Koller C A, O'Brien S, Plunkett W and Estey E. 19961024. Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults. : Leukemia.

Harvard

Kornblau S. M., Gandhi V., Andreeff H. M., Beran M., Kantarjian H. M., Koller C. A., O'Brien S., Plunkett W. and Estey E. (19961024). Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults. : Leukemia.

MLA

Kornblau S M, Gandhi V, Andreeff H M, Beran M, Kantarjian H M, Koller C A, O'Brien S, Plunkett W and Estey E. Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults. : Leukemia. 19961024.